July 17, 2013
Inflamax Research Selects OmniComm Systems’ eClinical Suite to Enhance Clinical Operations
May 21, 2013
Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation.
April 9, 2013
Inflamax Research Chosen to Conduct a Multicenter Environmental Exposure Chamber Phase 3 Study of Ultrashort Grass Allergy Vaccine by Allergy Therapeutics (UK) Ltd.
February 27, 2013